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doi:10.1016/j.jds.2011.09.008Abstract Background/purpose: Sickle cell disease (SCD) is a chronic, hereditary, autosomal
recessive disorder. The pathophysiology of SCD is thought to result from polymerization of
hemoglobin S in red blood cells under hypoxic conditions, which results in vaso-occlusion.
The aim of this study was to determine the periodontal and dental health status of patients
with SCD.
Materials and methods: Fifty-five SCD patients and 41 healthy individuals were evaluated.
Detailed medical and dental histories were taken, and a record made of dental status (missing
teeth, restorations, impacted teeth, root canal treatment), periodontal status [plaque index
(PI), gingival index (GI), probing depth (PD), bleeding on probing (BOP)], alveolar bone level
(ABL), mandibular cortex index, and bone quality index.
Results: Two hundred and six teeth were missing, and a total of 195 teeth had restorations.
Between-group differences existed for the PI, GI, and BOP; these variables were higher in
patients than in the healthy individuals (P< 0.0001). No between-group differences existed
for PD. In patients, there was a positive correlation between PD and BOP (P < 0.0001;
rZ 0.657), PD and GI (PZ 0.02; rZ 0.299), PD and PI (PZ 0.01; rZ 0.343); BOP and GI
(P < 0.0001; rZ 0.503), BOP and PI (P < 0.0001; rZ 0.496); and GI and PI (PZ 0.003;
rZ 0.388). The ABL in patients was found to be similar to that of the general population with
an unknown periodontal condition.
Conclusion: No clinical periodontal disease or attachment loss was detected in patients.
However the PI, GI, and BOP were significantly higher in patients with SCD, which may reflect
an as yet undefined variable response to microbes. There were no significant differences,ve no conflict of interest. No external funding, apart from that of authors’ institutions, was available
of Periodontology, Faculty of Dentistry, Kocaeli University, Yuvacik Yerleskesi, Pasadag Mah, 41190
(E. Guzeldemir).
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228 E. Guzeldemir et alhowever, in pocket depth between the two groups. Therefore we are unable to confirm any
significant relationship between SCD and periodontal diseases. Oral health is not a major
concern for SCD patients. The reason for this finding may be the potentially severe complica-
tions of SCD, which mean that oral and dental problems are not major concerns for this partic-
ular group of patients.
Copyright ª 2011, Association for Dental Sciences of the Republic of China. Published by
Elsevier Taiwan LLC. All rights reserved.Introduction
Sickle cell disease (SCD) is a hereditary, autosomal reces-
sive disorder. This chronic disorder has been linked to
hypoxia. The pathophysiology of SCD is thought to result
from polymerization of hemoglobin S in red blood cells
(RBCs) under hypoxic conditions, which results in the
occlusion of blood vessels. The single amino-acid change in
the beta subunit causes sickle hemoglobin to polymerize,
especially under low oxygen tension. Polymerization causes
the RBCs to deform into the characteristic sickle shape,
thus plugging blood vessels.1 A decrease in the tissue pH
and oxygen tension leads to further sickling. When hemo-
globin S accounts for <40% of the patient’s hemoglobin,
sickling occurs only under conditions of severe hypoxia.
The common clinical manifestations of SCD are vaso-
occlusive crises, avascular necrosis (AVN), and osteomye-
litis.2 Hemoglobin S polymerization can lead to hemolysis,
inflammation, cell adhesion, ischemia-reperfusion injury,
infarction, endothelial dysfunction, increased superoxide
production, and characteristic vaso-occlusive crises resulting
from acute vascular obstruction and vascular dysfunction.3
A sickle cell crisis may be precipitated by dehydration,
acidosis, trauma, overexertion, surgery (including tooth
extraction), infections, general anesthesia, temperature
extremes, vascular occlusion, and pulmonary disease.
Patients may have fatigue and weakness; pain in the long
bones, joints, and abdomen; cardiomegaly; systolic
murmur; epistaxis; icteric sclera; bone deformities; and
pallor of the oral mucosa.4 Problems in the cardiopulmo-
nary system, kidneys, bone, and central nervous system,
and ophthalmic complications develop secondary to
damage caused by vaso-occlusive episodes in the respective
capillary networks.
Patients with SCD are more prone to infections because
of hyposplenism, which occurs as a result of repeated
infarctions leading to atrophy and an autosplenectomy.
Impaired splenic functions lead to impaired removal of
microorganisms from the blood. Changes in body temper-
ature and tissue pH that occur as a result of infection may
precipitate a vaso-occlusive crisis.
Although oral problems were described in the literature,
these are less common than other medical problems. Oral
problems such as unilateral infarct of the mandible,5,6
pulpal necrosis,5,7 osteonecrosis,8 facial swelling,1 dia-
stema, hypodontia,9 gingival enlargement,1 palatal pallor,4
increased risk for caries,10 osteomyelitis of the mandible,11
unilateral anesthesia,6,8 midfacial overgrowth,4 and orofa-
cial pain4,11,12 were reported.13
Findings on panoramic radiographs may include an
enlarged medullary space, a stepladder-like effect on thebone, enamel hypomineralization, calcified pulp canals, an
increased prevalence of mandibular osteomyelitis, and
thinning of the inferior border of the mandible.4,8,13,14
Digital analysis of the trabecular pattern in the jaws of
patients with SCD revealed a less complex trabecular
structure in both the maxilla and the mandible.15,16
The aim of this paper is to present dental and peri-
odontal views of patients with SCD who had been sent to
the periodontology department for a consultation. This
paper also presents current knowledge and suggestions for
SCD patients in dental practice.Materials and methods
The study protocol was approved by the Ethics Committee
of the Medical Faculty of Baskent University, in accordance
with the Declaration of Helsinki (D-KA06/04). SCD patients
are regularly evaluated at the hematology clinics of Bas-
kent University. They are sent to the periodontology
department for dental and periodontal examinations and
consultations as part of a standard medical examination.
Written, informed consent was obtained from all partici-
pants before their examination. Participants’ genotypes
were confirmed by electrophoresis. Complete medical and
dental histories were noted, radiographic examinations
were done, and data regarding smoking habits, consan-
guineous marriages, previous surgeries (especially a sple-
nectomy), and a record made of the existence of
osteoporosis, hepatitis, and physical disabilities.
The plaque index (PI; Silness and Lo¨e) and gingival index
(GI; Lo¨e and Silness) were scored; probing depth (PD) was
measured in millimeters with a Williams periodontal probe
(Carl Martin, Solingen, Germany). Bleeding on probing
(BOP) was recorded as absent or present from four aspects
(mesial, buccal, distal, and palatinal/lingual) of all existing
teeth, with the exception of third molars, in the mouths of
all subjects.
Fillings, missing teeth, impacted teeth, tooth canal
treatments, and periapical lesions were recorded. All
panoramic radiographs were taken by the same experi-
enced radiograph technician, and assessed by an experi-
enced periodontist.
Mandibular cortex widths, the mandibular cortex index
and bone quality index, and alveolar bone level were
recorded from the panoramic radiographs.
Mandibular cortex widths were measured as the height
of the inferior cortex on the left side of the mandible
divided by the height of the lower border of the mandible
to the edge of the mental foramen.17e19 The mandibular
cortex index describes the appearances of the lower
Oral health status of SCD patients 229mandibular inferior cortical shape as smooth (C1), with
semilunar erosions (C2), or as porous, severely eroded
(C3).18,19
Bone quality was assessed by a bone quality index.18 The
bone quality index describes bone quality on the basis of
the amount and proportion of cortical and trabecular bone;
the four classes are: homogenous cortical bone; thick
cortical bone with a marrow cavity; thin cortical bone with
dense trabecular bone of good strength; and very thin
cortical bone with low-density trabecular bone of poor
strength.18
The alveolar bone level was measured with a Bjo¨rn and
Holmberg ruler,20 which had previously been used by our
group.21,22 This transparent ruler has six divisions, and
determines the height of the interdental alveolar bone as
a proportion of the total length of the tooth. The ruler was
applied over the radiographs, with the coronal baseline
falling over the incisal edge or crown tip of the tooth to be
measured. The inclination of the coronal baseline toward
the image is essential. The mesial and distal aspects of each
tooth, with the exception of the third molars, were indi-
vidually measured and recorded. The optimal bone height
was considered to be 65% of the total tooth length. This
“optimal bone height” was divided into four equal portions,
scored as 1, 2, 3, and 4, and a score of “0” indicates 65%
5% of the total root length. The scoring system is summa-
rized as follows: 0Z no or initial marginal bone loss;
1Z<25% of the total tooth length lost; 2Z<50% and
>25% of the total tooth length lost; 3Z<75% and >50% of
the total tooth length lost; and 4Z>75% (severe) alveolar
bone loss.
The radiographic data obtained from patients with SCD
were compared to data obtained from patients with an
unknown periodontal condition. Detailed information about
this population was previously documented in detail.21,23,24Results
Demographic evaluations
We clinically evaluated 55 SCD patients (30 women and 25
men; mean age 31.1 9.7 years) with homozygous SCD in
a steady-state condition and 41 healthy, age- and sex-
matched controls (25 women and 16 men; mean age
27.8 6.3 years) with no history of SCD; the panoramicTable 1 Epidemiologic data regarding to age, sex, and
smoking habits.
SCD Control P
Sex
Female 30 25 NS
Male 25 16
Age (years) 31.1 9.7 27.8 6.3 NS
Consanguinous marriages 31.4% N/A
Smoking 5.9% 2.4% NS
SCDZ sickle cell disease.radiographs of 54 SCD patients were evaluated. No signifi-
cant between-group differences were recorded with regard
to age, sex, or smoking habits (Table 1). Consanguineous
marriages existed in 31.4% of the SCD patients.
Medical evaluation
Forty-nine percent of SCD patients had at least one another
medical problem; these problems included complications of
SCD such as cardiovascular diseases, ophthalmic disorders,
and long-bone pain, and 40.4% of them had avascular
necrosis in their hips and scapulas (Table 2).
No significant differences existed between the number
of erythrocyte transfusions and the rate of having a crisis in
the previous 3 years.
During our research, while neither periodontal infections
nor abscesses contributed to vaso-occlusive crises, two
patients were sent to the dental clinic for consultation soon
after control of a vaso-occlusive crisis. Both patients had
deep caries and periapical lesions with submandibular
swelling.
Periodontal and dental evaluations
Significant between-group differences existed for PI scores
(P< 0.0001), GI scores (P< 0.0001), and BOP positive sides
(P< 0.0001). These variables were higher in the SCD group.
No between-group differences existed for PD (P> 0.05)
(Table 3).
In the SCD group, positive correlations were found for
PD, PI, GI, and BOP; and between PD and BOP (P< 0.0001;
rZ 0.657), PD and GI (PZ 0.02; rZ 0.299), PD and PI
(PZ 0.01; rZ 0.343), BOP and GI (P< 0.0001; rZ 0.503),
BOP and PI (P< 0.0001; rZ 0.496), and GI and PI
(PZ 0.003; rZ 0.388) (Table 4). In the controls, only GI
was correlated with PD (PZ 0.01; rZ 0.370) and BOP
(P< 0.0001; rZ 0.695) (Table 5).
Two hundred and six teeth were missing, and 44.66% of
these were first and second molars. There were 105 fillings
(7.77% of the existing teeth), 90 crowns or bridges (6.47%),
and 11 teeth which were beyond repair (0.79%) detected
(Table 6).
Evaluation of panoramic radiographs
Fifty-four panoramic radiographs belonging to SCD patients
were evaluated for dental aspects (periapical lesions,
impacted and missing teeth, root canal treatment, and the
mandibular cortex index). One panoramic radiograph couldTable 2 Medical health condition of patients with sickle
cell disease (SCD).
Avascular necrosis 40.4%
Systemic disease (at least one other than SCD) 49%
Hepatitis history 32%
Erythrocyte transfusion (in past 2 y) 44.4%
Having crisis (in past 2 y) 78.3%
Hospitalization (in past 2 y) 71.8%
Table 3 Periodontal parameters in patients with sickle cell disease (SCD) and controls.
Periodontal parameters SCD Controls P
Plaque index (mean ss) 1.81 0.78 (medianZ 1.96) 0.19 0.17 (medianZ 0.14) <0.0001
Gingival index (mean ss) 0.46 0.39 (medianZ 0.34) 0.16 0.12 (medianZ 0.14) <0.0001
Probing depth (mean ss) 1.94 0.5 (medianZ 1.8) 1.94 0.2 (medianZ 1.97) NS
Bleeding on probing (% ss) 26.6 19.1 (medianZ 23.0) 6.4 4.8 (medianZ 5.0) <0.0001
230 E. Guzeldemir et alnot be evaluated because it was kept by the patient at his
request.
Thirty-nine root canal treatments were detected in
54 patients. Of these treated teeth, 90% had radiolucent
areas or a widening of the periodontal ligament in the
periapical region without clinical symptoms.
Forty periapical lesions (2.88%), 39 root canal treat-
ments (2.81%), 11 teeth beyond repair, and 24 impacted
teeth were seen (Table 6).
A stepladder-like effect was seen at interradicular sites
in 23.7% of patients. Osteoporotic changes were detected
in the body of the mandible in 37.1% of SCD patients. The
mean mandibular cortex width was calculated to be
4.32 mm. The distribution of scores was found to be 26.4%,
45.3%, and 28.3% for the mandibular cortex index, and
5.7%, 7.5%, 35.8%, and 50.9% for the bone quality index in
patients with SCD.
Alveolar bone levels at mesial and distal sites are shown
in Table 7. A score of 1 was the most frequent score at both
mesial and distal sites in all cases.Discussion
SCD was first described in 1910, in a black West Indian
dental student who presented with pulmonary symptoms,
and the physical and chemical properties of hemoglobin of
individuals with SCD were identified by Pauling et al.25
SCD was first recognized in people of West African
ancestry. Hemoglobin S occurs with the greatest prevalence
in tropical Africa; the heterozygote frequency is usually
about 20%, but in some areas reaches 40%. The sickle cell
trait has a frequency of about 8% in AfricaneAmerican
populations. The hemoglobin S gene is found to a lesser
extent in the Middle East, northern Greece, countries
bordering the Mediterranean (Sicily and other parts of
southern Italy, Turkey along the southeastern coast, and
Saudi Arabia, especially the eastern province), the African
coast, and in aboriginal tribes in India.3,26 On occasion, SCD
is found in people of European extraction, especially when
racial admixture has occurred over the centuries.3Table 4 Correlations between periodontal parameters in patie
SCD
group
PI GI
PI
GI PZ 0.003; rZ 0.388
PD PZ 0.01, rZ 0.343 PZ 0.02, r
BOP P< 0.0001, rZ 0.496 P< 0.0001,
BOPZ bleeding on probing; GIZ gingival index; PDZ probing depth;SCD may be diagnosed in the 16th week of gestation, but
manifestations do not appear until the 6th month after
birth.27 The National Cooperative Study of Sickle Cell
Disease estimated that the median survival of individuals
with SCD is 42 years for men and 48 years for women.28 The
mean age of examined patients with SCD in the present
study was 31 years. Platt et al29 reported the death of
patients with SCD over the age of 20 years. During a 2-year
period, two of 55 patients who were examined in our
hematology clinic died; they were males, aged 20 and 24
years respectively. The reason for the low number of deaths
may be related to the peak incidence of death that occurs
between 1 and 3 years of age (deaths among patients
younger than 20 years are predominantly caused by pneu-
mococcal sepsis) or to our study cohort being well main-
tained patients. Although men are at greater risk of early
death than women, there was no evidence that the risk
factors for early death differed according to sex in SCD
patients.28
Pulmonary hypertension, acute chest syndrome, and
sepsis have been reported as reasons for sudden death in
adult patients.28,30 Another sudden death risk arises from
excessive exercise; reduction in pH and temperature at
tissue level facilitates oxygen delivery during exercise, and
these changes lead to higher concentrations of deoxygen-
ated hemoglobin.31 Infections and sepsis remain the most
common causes of death and vaso-occlusive crises for
patients with SCD, and dental or periodontal infections4
may play a part in precipitating a crisis.
There is no cure for SCD, and management of this
disease is usually unsatisfactory. The prognosis of SCD
patients is not known; however, individuals with SCD have
a severe clinical course with acute pain and often require
hospitalization for vaso-occlusive crises and other compli-
cations of the disease.29,30 Although all of the patients
evaluated in our clinic were well maintained by our
hematology clinic, 72% of them had been hospitalized
during the past 2 years, and the mean number of days spent
in hospital per year was 28 days. Seventy-eight percent of
these patients had a mean of seven crises per person during
the past 2 years. Sickling is undoubtedly an importantnts with sickle cell disease (SCD).
PD BOP
Z 0.299
rZ 0.503 P< 0.0001; rZ 0.657
PI[ plaque index.
Table 5 Correlations between periodontal parameters in
control group.
Control
group
PI GI PD BOP
PI NS NS NS
GI PZ 0.01; rZ 0.370 P< 0.0001; rZ 0.695
PD NS
BOP
BOPZ bleeding on probing; GIZ gingival index; PDZ probing
depth; PI[ plaque index.
Table 7 Alveolar bone level (ABL) scores according to
mesial and distal sites for all patients.
ABL Scores ABL e mesial ABL e distal
0 33.3 21.3
1 52.7 54.1
2 11.2 20.6
3 1.2 2.4
4 0.3 0.5
Undecipherable 1.3 1.2
Oral health status of SCD patients 231accelerator of organ destruction and organ failure; this
could explain why 49% of our patients had another systemic
disease other than SCD.
In the present study, the plaque and gingival indices
were significantly higher in SCD patients than in healthy
individuals. Usually, oral health is not a primary concern of
SCD patients. In the current evaluation, no significant
differences existed regarding the PD between patients with
SCD and healthy individuals. These results agree with the
findings of Crawford32 and Arowojolu and Savage.33 Craw-
ford32 suggested that SCD is not associated with increased
levels of gingivitis and periodontitis in patients with SCD. In
agreement with the results of a study by Crawford,32 Aro-
wojolu and Savage33 found no significant difference in
alveolar bone loss patterns between patients and controls.
In the same study group, Arowojolu34 found no clinical
periodontal disease or attachment loss in patients with
SCD. However, in the present study, the number of BOP-
positive sites was greater in SCD patients than in controls,
but there was no clinical attachment loss. Clinically,
gingival tissues in SCD patients in our group appeared faded
and yellowish, which is compatible with previous reports.
SCD has long been recognized as an inflammatory
condition. This ongoing inflammatory state seems to
contribute to sickle cell complications. In the present
study, patients were examined when they were in a steady-
state condition. Steady-state disease does not necessarily
mean an absence of ongoing pathophysiologic activity, as
shown by the elevation and fluctuation of acute-phase
reactants and cytokines in patients with steady-state
SCD.35e37 High levels of endothelial progenitor cells in the
circulation can indicate endothelial activation andTable 6 Evaluation of panoramic radiographs.
Teeth Fillings Prosthetic
restorations
Root canal
treatment
Centrals 11 11 2
Laterals 6 11 1
Canines 2 17 8
1st premolars 10 6 6
2nd premolars 10 18 6
1st molars 38 8 9
2nd molars 28 19 7
3rd molars
Total 105 90 39inflammation.38 In another study, human subjects with and
without periodontal disease were cross-sectionally exam-
ined.39,40 Gingival inflammation directly correlated with
the level of periodontal disease, the level of putative
pathogens, and the level of short-chain carboxylic acids
(SCCAs).40 SCCAs are metabolic intermediates that occur in
and are released by bacteria and animal cells. On a site
basis, however, when probing depth, tooth location, and
bacteria were controlled for, gingival inflammation was
significantly correlated only with the concentrations of
propionic and butyric acids, not with the level of any single
putative pathogen.39 These experimental findings support
the hypotheses that bacterially derived SCCAs are associ-
ated with human gingival inflammation, are not associated
with gingival health, decrease following therapy, and can
elicit a clinically defined gingival inflammatory response.41
SCCAs may stimulate an inflammatory response by
increasing leukocyte recruitment, viability, and cytokine
gene expression of neutrophils.41 It is remarkable that
SCCAs stimulate an inflammatory response when placed on
healthy human gingiva. In addition to stimulating an
inflammatory response, potential therapeutic uses for
SCCAs would have been identified for SCD patients. Butyric
acid is normally used as a food additive, and it may increase
the amount of fetal hemoglobin in the blood. An intrave-
nous infusion of butyric acid into patients with SCD drives
the anemia into remission by downregulating sickle globin
gene expression and upregulating fetal globin gene
expression. It may be possible to begin to test and identify
pharmaceutical agents which diminish the harmful aspects,
while enhancing the beneficial components of the inflam-
matory response (for reviews, see Perrine et al,42 Schlake
et al,43 Orkin et al,44 and Niederman et al41).Periapical
lesion
Teeth
beyond repair
Impacted
teeth
Missing
teeth
9 2 5
4 5
4 1
9 1 19
13 3 29
21 7 71
20 21
21 56
40 11 24 206
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mediation, and leukocyte-derived mediators contribute to
the inflammatory response and in turn affect vascular tone
and permeability. Mononuclear cells from SCD patients
release more superoxide than do healthy controls when
stimulated with 12-O-tetradecanoylphorbol-13-acetate
(TPA), also commonly known as tetradecanoylphorbol
acetate, tetradecanoyl phorbol acetate, and phorbol 12-
myristate 13-acetate (PMA) and zymogen.45 Nitric oxide is
an important vasodilator. Superoxide inactivates nitric
oxide and produces oxidant damage.46 Dias-Da-Motta et al45
suggested that this phenomenon could represent an addi-
tional risk factor for obstructing the microcirculation and
causing tissue damage in SCD patients. Once oxidative
damage occurs in RBCs, hemoglobin denatures, and Fe3þ
interacts with the RBC membrane causing lipid perox-
idation, membrane damage, inactivation of membrane
enzymes, and DNA damage.47 Ozdogu et al48 demonstrated
that apoptosis of blood leukocytes is increased in patients
with SCD compared to controls. Conversely, few apoptotic
cells are apparent in the inflammatory infiltrates of peri-
odontitis tissue. Lard et al49 showed that neutrophils are
activated in SCD patients, suggesting an important role in
the pathophysiology of SCD. The observed neutrophil acti-
vation in sickle cell patients may lead to increased adher-
ence to the endothelium in the microcirculation. For
instance, neutrophils in localized aggressive periodontitis
are already primed (activated), and superoxide levels are
increased. The result in patients with localized aggressive
periodontitis is severe periodontal destruction that cannot
be explained by bacterial invasion. Similarly, neutrophils in
SCD patients are activated, and a high amount of plaque
was observed. However, the clinical appearance was not
compatible with these findings. We suggest that one of the
reasons for this incompatibility (characteristic of patients
with SCD) would be the vascular pathobiology.
The management of chronic pain in SCD is usually ach-
ieved by nonsteroidal anti-inflammatory agents (NSAIDs).
Adjunctive therapeutic strategies that modulate inflam-
matory mediators can play a significant part in periodontal
therapy. It was shown that the use of NSAIDs as an adjunct
to nonsurgical management of chronic periodontitis caused
a significant decrease in the probing depth.50 The results of
host modulation studies showed that this approach may be
a potential target to reduce tissue destruction. NSAIDs
block proinflammatory cytokines; a subdose of doxycycline
blocks metalloproteinases, and bisphosphonates block
osteoclast activity.51,52 Adjunctive anti-inflammatory
therapy may lead to a faster and greater reduction in
probing pocket depth than conventional periodontal
therapy.53 So, the regular use of NSAIDs by SCD patients
may result in prevention of periodontal destruction in those
patients.
Patients with SCD are susceptible to overwhelming
infection. Patients with SCD and unexplained fever should
be thoroughly examined.54 If the clinical condition suggests
septicemia, broad-spectrum antibiotics should be
prescribed. Continued use of antibiotics by SCD patients
can control periodontal destruction.
Sometimes, the severity of anemia in patients with SCD
gradually increases as they age. The reason for this marrow
“burn-out” phenomenon is unknown. The clinical situationis complicated by the fact that many patients have organ
damage, such as dilated cardiomyopathy, that may limit
their ability to tolerate such severe anemia.54 Also, the
cumulative effects of periodontal diseases are apparent in
older persons.55 In the present study, the mean age of the
SCD patients was 31 years; hence it was not surprising to
detect less periodontal destruction in spite of the presence
of higher plaque and gingival indices.
SCD complications place patients at risk for poor
psychosocial adaptation, including depression and anxiety
symptoms. Hijman et al56 showed that children with SCD
are at increased risk of developing severe internalizing
problems as a result of their disease. Subgroups of children
with SCD also appear to be at increased risk of developing
severe externalizing problems, which may be related to
either sociodemographic factors or disease factors, such as
neurocognitive deficits associated with cerebral infarction.
Children with SCD are also perceived to have more diffi-
culties than healthy siblings in school functioning, demon-
strate less-competent social behavior, and tend to have
more attention deficits. Carpenter et al57 reported that
adolescents with SCD who classified themselves as having
high behavioral inhibition displayed higher levels of anxiety
and depression than adolescents with SCD who classified
themselves as having low behavioral inhibition; adolescents
with SCD in the middle behavioral inhibition category
generally scored in between the other two categories.
Oral health is an integral and critical part of general
health. Our observation that “oral health is not a priority
for patients with sickle cell disease” is supported by the
increased amount of plaque together with the higher
number of missing teeth when considering the patients’
ages in our study group. This may also explain why the
mean PD was 1.94 mm despite higher plaque scores.
Although all patients were offered free dental treatment
and scaling and they were aware of the inadequacy of their
oral health, only a few patients applied for treatment of
their acute problems. The reason for this may have been
severe complications of SCD. Another possible reason for
less periodontal destruction would be patients’ preference
for tooth extraction in lieu of treatment. Treatments were
provided to patients by experienced dentists and peri-
odontists. Although oral hygiene did not reach satisfactory
levels, no further dental or periodontal problems were
detected. Hence, oral problems are not a major concern for
this group of patients, as we have demonstrated. Patients’
perceptions of the social and behavioral consequences of
their oral conditions and their treatment likely have an
important influence on their behavior toward oral health
and their patterns of dental care utilization. Assessing
patients’ motivations and their desire to retain the natural
dentition is an important component of a treatment plan.
Most patients have complex medical conditions. In addi-
tion, it was reported that most patients experience
depression, anxiety disorders, or somatoform disorders of
which dentists need to be aware.
Acute bone problems in SCD were described by Almeida
and Roberts2 as vaso-occlusive crises, osteomyelitis, stress
fractures, orbital compression, dental complications,
vertebral collapse, and bone marrow necrosis; chronic bone
problems were described as osteonecrosis, chronic
arthritis, osteoporosis, and impaired growth. Most SCD
Oral health status of SCD patients 233patients have joint and bone disease, especially pain
caused by hip and scapular joint calcification, and 40.4% of
the patients in our group had AVN in their hips and scapulas.
Avascular necrosis or osteonecrosis occurs when vaso-
occlusion results in an infarction of the articular surfaces
and heads of the long bones.2 Maxillofacial involvement,
especially of both the maxillary and mandibular jaw bones,
is estimated to be between 79% and 100% in SCD.5,16
In studies performed by Rohlin et al,58,59 panoramic
radiographs were found to be equivalent to periapical
radiographs for the upper-jaw, but inferior to periapical
radiographs for the lower jaw. As long as an ideal image
quality can be achieved, panoramic radiographs can be
used for dental and periodontal evaluations.
Previously, panoramic radiographs were used to identify
postmenopausal women at risk of osteoporosis.17,19,60,61 In
panoramic radiographs, osteoporotic patients were shown
to have a lower jaw bone mineral density than controls.18
Brinker et al62 showed an overall reduction in bone
mineral density in children with SCD compared to normal
subjects. Almost half of our SCD group had semilunar
erosions in their mandibular cortex, and 87% of them had
low-quality bone compatible with their medical history
obtained from medical records. It is clear that panoramic
radiographs are still useful diagnostic tools.
Routine treatment can be carried out during noncrisis
periods; therapy during crises should be limited to pallia-
tion. Ideally, a dental appointment should be scheduled in
the morning with minimum treatment and a short visit.
Antibiotic prophylaxis is recommended before all dental
treatments. Local anesthetics with a vasoconstrictor can
safely be used in these patients, because it is known that
local circulation is adequate. Acetyl salicylic acid is not
recommended because of the risk of inducing acidosis;
acetaminophen and codeine combinations provide the best
oral analgesia.13,63 Dentists should be aware of dental pain
of unknown cause in SCD patients. Dental pain in the
absence of caries may be caused by an intrapulpal infarct,
asymptomatic pulpal necrosis, or blockage of tiny pulpal
vessels by sickle cell emboli.7,13 If root canal treatment is
not satisfactorily performed, an improperly filled tooth root
may be a reason for a vaso-occlusive crisis because of
inflammation.8
Conclusions
Appropriate dental and periodontal care improves
a patient’s quality of life by preventing eating difficulties,
oral diseases, and esthetic concerns, and facilitates the
management of the disease by the hematologist. Preven-
tive dental care is essential for SCD patients.
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